Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Chen, Xin ^a   Li, Wen Ling ^a   Zhang, Yi Li ^b   Wu, Qian ^c   Guo, You Min ^b   Bai, Zhi Lan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST TUMOR; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PUBLISHING; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BREAST DISEASE; CHI SQUARE DISTRIBUTION; FEMALE; PREDICTIVE VALUE;

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

BREAST DISEASES; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 78650595512     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-693     Document Type: Article

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 2004, 86:31-37. 10.1023/B:BREA.0000032921.10481.dc, 15218359.
3. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG, . Magnetic Resonance Imaging Screening Study Group Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427-437. 10.1056/NEJMoa031759, 15282350, Magnetic Resonance Imaging Screening Study Group.
4. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006, 238:42-53. 10.1148/radiol.2381042117, 16373758.
5. Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 2006, 32:901-910. 10.1016/j.ejso.2006.06.009, 16920327.
6. Peters NHGM, Borel Rinkes IHM, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008, 246:116-124. 10.1148/radiol.2461061298, 18024435.
7. Kuhl CK. Concepts for differential diagnosis in breast MR imaging. Magn Reson Imaging Clin N Am 2006, 14:305-328. 10.1016/j.mric.2006.07.002, 17098173.
8. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: application and challenges in oncology. Am J Roentgenol 2007, 188:1622-1635.
9. Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H, Imai Y. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008, 26:222-226. 10.1007/s11604-007-0218-3, 18509722.
10. Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 2003, 45:208-213. 10.1016/S0720-048X(02)00310-8, 12595105.
11. Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, Mahankali S, Gao J. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002, 16:172-178. 10.1002/jmri.10140, 12203765.
12. Sinha S, Lucas-Quesada FA, Sinha U, Debruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002, 15:693-704. 10.1002/jmri.10116, 12112520.
13. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005, 4:35-42. 10.2463/mrms.4.35, 16127252.
14. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006, 24:319-324. 10.1002/jmri.20643, 16786565.
15. Kuroki Y, Nasu K, Kuroki S, Murakami K, Hayashi T, Sekiquchi R, Nawabo S. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004, 3:79-85. 10.2463/mrms.3.79, 16093623.
16. Luo J, Liu Y, Zhang L, Shi L. Application of diffusion weighted magnetic resonance imaging to differential diagnosis of breast diseases. Ai Zheng 2007, 26:168-171.
17. Park MJ, Cha ES, Kang BJ, Ihn YK, Jun HB. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007, 8:390-396. 10.3348/kjr.2007.8.5.390, 2626812, 17923781.
18. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007, 17:2646-2655. 10.1007/s00330-007-0621-2, 17356840.
19. Diagnostic Systematic Reviews: A Road Map (Version 3). , http://www.medepi.net/meta/guidelines/Diagnostic_Systematic_Reviews_Road_Map_V3.pdf.
20. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
21. Whiting P, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, A Tool for the Quality Assessment of Diagnostic Accuracy Studies (update). BMC Med Res Methodol 2006, 6:9. 10.1186/1471-2288-6-9, 1421422, 16519814.
22. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
23. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31. 10.1186/1471-2288-6-31, 1552081, 16836745.
24. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316.
25. Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 2002, 31:88-95. 10.1093/ije/31.1.88, 11914301.
26. Song F, Eastwood A, Gilbody S, Duley L, Sutton AJ. Publication and related biases. Health Technol Assess 2000, 4:10.
27. Orwin R. A fail-safe N for effect size in Meta-analysis. J Educ Behav Stat 1983, 8:157-159.
28. Persaud R. Misleading Meta-analysis: "Fail-safe N" is a useful mathematical measure of the stability of results. BMJ 1996, 312:125. 2349768, 8555918.
29. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001, 323:157-162. 10.1136/bmj.323.7305.157, 1120791, 11463691.
30. Comprehensive Meta-analysis version 2. , http://www.meta-analysis.com/index.html
31. Zhang YL, Huang X, Du H, Zhang Y, Chen X, Wang P, Guo Y. The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma. BMC Cancer 2009, 9:18. 10.1186/1471-2407-9-18, 2633008, 19144163.
32. Matsuoka A, Minato M, Harada M, Kubo H, Bandou Y, Tangoku A, Nakano K, Nishitani H. Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008, 26:15-20. 10.1007/s11604-007-0187-6, 18236129.
33. Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H, Imai Y. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008, 26:222-6. 10.1007/s11604-007-0218-3, 18509722.
34. Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 2001, 14:433-8. 10.1002/jmri.1204, 11599068.
35. Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, Honda TM. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008, 7:23-29. 10.2463/mrms.7.23, 18460845.
36. Feng Y, Liu S, Wang C, Tao X, Wang J, Wang J. Application of functional MRI in breast diseases. Chin J Radiol 2007, 41:457-462.
37. Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008, 28:1157-65. 10.1002/jmri.21570, 18972357.
38. Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, Watanabe M, Hayakawa K. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005, 29:644-649. 10.1097/01.rct.0000171913.74086.1b, 16163035.
39. Guo Y, Cai Z, Cai Y, Ning A, Gao Y, Ma L, Liang Y. Differentiation of benign from malignant breast lesions by apparent diffusion coefficients. Chin J Radiol 2001, 35:132-135.
40. Balzer PAT, Renz DM, Herrmenn KH, Krumbein I, Gajda M, Camara O, Reichenbach JR, Kaiser WA. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009, 19:1612-1620. 10.1007/s00330-009-1326-5, 19288109.
41. Huang X, Du H, Zhang Y, Zhang Y. The value of MR diffusion-weighted imaging in diagnosing the benign and malignant breast lesions. J Pract Radiol 2008, 24:526-533.
42. Jin G, Cai Y, An N, Li X, Liu M, Wang J. Clinical application of diffusion-weighted imaging with ASSET technique for breast lesions. Clinical Radiology 2008, 27:796-799.
43. Tang J, Yan F, Zhou M, Ye F, Xu P. Comparative study of diffusion weighted imaging and dynamic contrast enhancement MRI for the detection of small breast cancers. Chin J Radiol 2008, 42:152-156.
44. Gu Y, Fen X, Tang F, Peng W, Mao J, Yang W. Diffusion-weighted MRI in the breast: lesion characterization and parameter selection. Chin J Radiol 2007, 41:451-456.
45. Lou L, Zhang J, Shi G. The application of MR diffusion weighted imaging in differentiation of benign from malignant breast lesions. Clinical Radiology 2007, 26:350-353.
46. Li J, Zhang X, Cao K, Sun Y, Shan J, OuYang T. Clinical evaluation of combining dynamic contrast-enhanced MR imaging and diffusion-weighted MR imaging for diagnosis of breast lesion. Chinese Journal of Medical Imaging technology 2005, 21:1821-1825.
47. Zhao B, Cai SF, Gao PH, Peng HJ. The research on distinguishing benign from malignant breast lesions by diffusion-weighted MR imaging. Chin J Radiol 2005, 39:497-500.
48. Bossuyt P, Reitsma J, Bruns D, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, Vet HCW, Lijmer JG. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18. 10.1373/49.1.7, 12507954.